{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:39:43Z","timestamp":1793176783969,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacl.2026.07.036","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:53:39Z","timestamp":1785858819000},"page":"2267-2276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-6929","authenticated-orcid":false,"given":"Francinny Alves","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1604-6759","authenticated-orcid":false,"given":"Luis Henrique Rios","family":"Moreira R\u00eago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4864-5251","authenticated-orcid":false,"given":"Thiago Gorayeb","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2073-2043","authenticated-orcid":false,"given":"Raissa Martins","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-8804","authenticated-orcid":false,"given":"Fernando Rocha","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8447-7960","authenticated-orcid":false,"given":"Vladia","family":"Falcao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jacl.2026.07.036_bib1","first-page":"2982","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"issue":"6","key":"10.1016\/j.jacl.2026.07.036_bib2","first-page":"e893","article-title":"Safety and efficacy of moderate-intensity statin plus ezetimibe versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease: a meta-analysis","volume":"18","author":"Kelly","year":"2024","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"issue":"24","key":"10.1016\/j.jacl.2026.07.036_bib3","first-page":"3168","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"issue":"21","key":"10.1016\/j.jacl.2026.07.036_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.102.21.2672-f","article-title":"The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial: effects of intensive atorvastatin treatment on early recurrent events after an acute coronary syndrome","volume":"102","author":"Schwartz","year":"2000","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacl.2026.07.036_bib5","first-page":"1495","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"24","key":"10.1016\/j.jacl.2026.07.036_bib6","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.jacl.2026.07.036_bib7","first-page":"2387","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"11","key":"10.1016\/j.jacl.2026.07.036_bib8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/eurheartj\/ehac709","article-title":"Moderate-intensity statin with ezetimibe vs. high-intenity statin in patients with diabetes and atherosclerotic cardiovascular disease in RACING trial","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.07.036_bib9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jacl.2026.07.036_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.jacl.2026.07.036_bib11","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst\u00a0Rev"},{"key":"10.1016\/j.jacl.2026.07.036_bib12","unstructured":"Rayyan\u2014a web and mobile app for systematic reviews | Systematic Reviews [Internet]. Available from: https:\/\/link.springer.com\/article\/10.1186\/s13643-016-0384-4."},{"key":"10.1016\/j.jacl.2026.07.036_bib13","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2026.07.036_bib14","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jacl.2026.07.036_bib15","first-page":"153","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid\u00a0Based Ment\u00a0Health"},{"key":"10.1016\/j.jacl.2026.07.036_bib16","first-page":"35","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med\u00a0Res\u00a0Methodol"},{"issue":"18","key":"10.1016\/j.jacl.2026.07.036_bib17","first-page":"2641","article-title":"A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials","volume":"21","author":"Baujat","year":"2002","journal-title":"Stat\u00a0Med"},{"issue":"1","key":"10.1016\/j.jacl.2026.07.036_bib18","first-page":"396","article-title":"Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention","volume":"23","author":"Choo","year":"2024","journal-title":"Cardiovasc\u00a0Diabetol"},{"issue":"1","key":"10.1016\/j.jacl.2026.07.036_bib19","first-page":"838","article-title":"Comparative effectiveness of moderate-intensity statin with ezetimibe therapy versus high-intensity statin monotherapy in patients with acute coronary syndrome: a nationwide cohort study","volume":"14","author":"Jang","year":"2024","journal-title":"Sci\u00a0Rep"},{"issue":"3","key":"10.1016\/j.jacl.2026.07.036_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.12997\/jla.2021.10.3.291","article-title":"Comparison of the effects of high-intensity statin therapy with moderate-intensity statin and ezetimibe combination therapy on major adverse cardiovascular events in patients with acute myocardial infarction: a nationwide cohort study","volume":"10","author":"Kim","year":"2021","journal-title":"J\u00a0Lipid Atheroscler"},{"issue":"1","key":"10.1016\/j.jacl.2026.07.036_bib21","first-page":"141","article-title":"Moderate-intensity statins plus ezetimibe vs. high-intensity statins after coronary revascularization: a cohort study","volume":"37","author":"Kim","year":"2023","journal-title":"Cardiovasc\u00a0Drugs Ther"},{"issue":"8","key":"10.1016\/j.jacl.2026.07.036_bib22","first-page":"676","article-title":"Combination therapy with moderate-intensity atorvastatin and ezetimibe vs. high-intensity atorvastatin monotherapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability","volume":"10","author":"Lee","year":"2025","journal-title":"Eur\u00a0Heart J\u00a0Cardiovasc\u00a0Pharmacother"},{"key":"10.1016\/j.jacl.2026.07.036_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101933","article-title":"Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial","volume":"58","author":"Park","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.jacl.2026.07.036_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10557-025-07729-7","article-title":"Moderate-intensity atorvastatin and ezetimibe combination therapy versus high-intensity atorvastatin in patients with angina pectoris who underwent percutaneous coronary intervention","volume":"40","author":"Sohn","year":"2026","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10349","key":"10.1016\/j.jacl.2026.07.036_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","article-title":"Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial","volume":"400","author":"Kim","year":"2022","journal-title":"Lancet Lond\u00a0Engl"},{"issue":"6","key":"10.1016\/j.jacl.2026.07.036_bib26","first-page":"23","article-title":"Diabetogenic action of statins: mechanisms","volume":"21","author":"Carmena","year":"2019","journal-title":"Curr\u00a0Atheroscler\u00a0Rep"},{"issue":"2","key":"10.1016\/j.jacl.2026.07.036_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12020-018-1541-4","article-title":"Effect of ezetimibe on glycemic control: a systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Wu","year":"2018","journal-title":"Endocrine"},{"issue":"13","key":"10.1016\/j.jacl.2026.07.036_bib28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jacl.2026.07.036_bib29","first-page":"55","article-title":"Combination lipid-lowering therapies for the prevention of recurrent cardiovascular events","volume":"20","author":"Lee","year":"2018","journal-title":"Curr\u00a0Cardiol\u00a0Rep"},{"issue":"42","key":"10.1016\/j.jacl.2026.07.036_bib30","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:27:34Z","timestamp":1793176054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1933287426004654"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.036","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}